Investors
Pureos Bioventures
Pureos Bioventures is a venture capital fund based in Zürich, investing in early and growth-stage companies in the biotech, health tech, and pharma sectors. They support firms developing breakthrough solutions, such as MinervaX and Memo Therapeutics. Their mission is to advance healthcare and improve lives by providing essential capital to promising ventures.
Recent Investments
- MinervaXSeries C( 56 )
- Memo TherapeuticsSeries C( 37 )
- Engimmune TherapeuticsSeed( 33 )
- Ariceum TherapeuticsSeries A( 52 )
- Ariceum TherapeuticsSeries A( 52 )
- Araris BiotechSeries A( 44 )
- Corlieve TherapeuticsUnknown( 25 )
- EyevensysSeries B( 43 )
- Araris BiotechSeed( 44 )